A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis
In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…
Read More
Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study
A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech startup formerly known as Somite AI, has secured global rights to a clinical-stage Parkinson’s…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s.
A significant stride in the realm of integrated medicine has been reported by Remepy, a pioneering startup, as its innovative…
Read More
Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research
Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…
Read More
Novo Nordisk Transfers Parkinson’s Cell Therapy to Cellular Intelligence, Signaling New Era for AI-Driven Biopharma
In a significant development for the burgeoning field of cell therapy and artificial intelligence in drug discovery, Cellular Intelligence, a…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
In a significant advancement for integrated medicine, Remepy, a pioneering startup, has announced successful Phase IIa clinical trial results for…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a burgeoning biotechnology firm formerly known as Somite AI, has announced a significant strategic acquisition, securing global rights…
Read More
